No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Diagnostics & Research
Bangkok Genomics Innovation Public Company Limited, trading as BKGI.BK, is a Thailand-based enterprise delivering a diverse array of clinical and genomic services. Their core genetic offerings include the NIFTY brand for non-invasive prenatal testing, screening for fetal chromosomal abnormalities, and the VISTA brand, which provides genetic disease carrier screening for applications such as pre-embryo implantation, general carrier status, and the detection of gene anomalies linked to thalassemia anemia. Additionally, they offer HPV DNA testing, colon cancer screening under the COLOTECH brand, and personalized genetic analyses through the DNALL brand. Beyond genetic diagnostics, the company provides comprehensive testing for infectious diseases, including real-time PCR, antigen, serology, and neutralizing antibody assays for COVID-19, alongside real-time PCR testing for the monkeypox virus. Their technology solutions segment covers advanced services like DNA and RNA base sequencing, as well as metabolism and protein omics tests. The company also acts as a distributor for essential medical supplies, such as PCR COVID-19 test kits, personal protective equipment (PPE), and vital transport media. BKGI's broader service portfolio encompasses health analytics, medical care, and the development of biotechnology products. They also offer cell advanced therapy medicinal products and provide consulting services for small businesses. Furthermore, the company operates an education center, engages in research activities, and is involved in the retail sale of pharmaceutical products. Remarkably, their operations extend into other sectors, including the provision of heavy machinery such like hydraulic excavators, tractors, wheel-loaded air compressors, and their spare parts, in addition to real estate development. Founded in 2017, Bangkok Genomics Innovation Public Company Limited is headquartered in Bangkok, Thailand.
www.bangkokgenomics.comNo one on the platform currently holds BKGI.BK.
No tracked institution reports a position in BKGI.BK as of their last filing.
No one on the platform has traded BKGI.BK yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 11.4% | 42.2% | — | — | — | |
| Rev. Growth % | 12.4% | 23.2% | ||||
| Profit Margin % | 11.9% | 18.5% | ||||
| Free Cash Flow Margin % | -32.8% | 3.2% | ||||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $400M | +8.1% | $0.10 | $0.10–$0.10 | — | 1 |
| 2027 | $433M | +8.3% | $0.11 | $0.11–$0.11 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 5 of the last 6 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-19 | $0.02 | $0.05 | +157.5% |
| 2026-05-15 | $0.02 | $0.05 | +160.5% |
| 2025-08-13 | $0.01 | $0.01 | -28.4% |
| 2025-05-15 | $0.01 | $0.01 | +35.4% |
| 2025-02-26 | $0.02 | $0.02 | +0.0% |
| 2024-11-06 | $0.02 | $0.02 | +20.0% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| BKGI.BKBangkok Genomics Innovation Public Company Limited | $2.30 | -3.36% | $1.4B | — |
| AHC.BKAikchol Hospital Public Company Limited | $12.10 | +1.68% | $1.8B | — |
| BIZ.BKBusiness Alignment Public Company Limited | $6.05 | +0.00% | $3.6B | — |
| D.BKDental Corporation Public Company Limited | $3.02 | +0.00% | $1.0B | — |
| EFORL.BKE for L Aim Public Company Limited |
| $0.11 |
| +10.00% |
| $440M |
| — |
| HL.BKHealthlead Public Company Limited | $4.50 | +0.00% | $1.2B | — |
| IMH.BKIntermedical Care and Lab Hospital Public Company Limited | $3.68 | +0.00% | $872M | — |
Source: Financial Modeling Prep · peers by sector/industry